2018
DOI: 10.1021/acs.jmedchem.8b00686
|View full text |Cite
|
Sign up to set email alerts
|

Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs

Abstract: Two decades have passed since the rule of five ushered in the concept of "drug-like" properties. Attempts to quantify, correlate, and categorize molecules based on Ro5 parameters evolved into the introduction of efficiency metrics with far reaching consequences in decision making by industry leaders and scientists seeking to discover new medicines. Examination of oral drug parameters approved before and after the original Ro5 analysis demonstrates that some parameters such as clogP and HBD remained constant wh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

19
318
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 349 publications
(338 citation statements)
references
References 72 publications
19
318
1
Order By: Relevance
“…Ap ossible explanation would be the dominating lipophilic contribution by the 4-biphenyl substituent together with conformationalr estraintsd ue to the b-annelation. Furthermore,n oneo fthed escribed DHPs violates the extended 'rule-of-five' principles ( Table 2), [17] justifying more extended biological profiling and in vivo experimental pharmacology.…”
Section: Lipophilicity and Solubilitymentioning
confidence: 98%
“…Ap ossible explanation would be the dominating lipophilic contribution by the 4-biphenyl substituent together with conformationalr estraintsd ue to the b-annelation. Furthermore,n oneo fthed escribed DHPs violates the extended 'rule-of-five' principles ( Table 2), [17] justifying more extended biological profiling and in vivo experimental pharmacology.…”
Section: Lipophilicity and Solubilitymentioning
confidence: 98%
“…optimal for a small molecule with good pharmacokinetic properties [34,35]. Contrary to the classical perspective, it is noteworthy that a G4 ligand that lacks traditional 'drug-like' properties has shown significant accumulation and efficacy in tumour xenografts of human cancers [29].…”
Section: Glossarymentioning
confidence: 99%
“…Bicker ton a n d collea gu es [74] in tr od u ced th e con cep t of th e q u a n tita tive estim a te of d r u g-liken ess (QED) (b u t see [75]), a n d it is of in ter est to see h ow 'd r u g-like' ou r fou r cla sses of m olecu le a r e b y th eir cr iter ia . Fig 5A sh ow s th e d istr ib u tion of QED d r u g-liken esses for m a r keted d r u gs, for Recon 2 m eta b olites, for ou r selected flu or op h or es, a n d for a sa m p le of 2000 m olecu les fr om UNPD.…”
Section: Resultsmentioning
confidence: 99%